Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Income towards Parent Company (2021 - 2025)

Historic Income towards Parent Company for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to $7.4 million.

  • Arcutis Biotherapeutics' Income towards Parent Company rose 11783.95% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.3 million, marking a year-over-year increase of 7733.19%. This contributed to the annual value of -$140.0 million for FY2024, which is 4657.85% up from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported Income towards Parent Company of $7.4 million as of Q3 2025, which was up 11783.95% from -$15.9 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Income towards Parent Company registered a high of $7.4 million during Q3 2025, and its lowest value of -$107.7 million during Q3 2022.
  • Over the past 5 years, Arcutis Biotherapeutics' median Income towards Parent Company value was -$52.3 million (recorded in 2024), while the average stood at -$50.2 million.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Income towards Parent Company plummeted by 8870.49% in 2022 and then surged by 11783.95% in 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Income towards Parent Company (Quarter) stood at -$71.3 million in 2021, then dropped by 1.03% to -$72.0 million in 2022, then grew by 7.96% to -$66.3 million in 2023, then soared by 83.72% to -$10.8 million in 2024, then surged by 168.69% to $7.4 million in 2025.
  • Its Income towards Parent Company stands at $7.4 million for Q3 2025, versus -$15.9 million for Q2 2025 and -$25.1 million for Q1 2025.